These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1184 related items for PubMed ID: 22172786
21. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Heinonen SE, Leppänen P, Kholová I, Lumivuori H, Häkkinen SK, Bosch F, Laakso M, Ylä-Herttuala S. Circ Res; 2007 Nov 09; 101(10):1058-67. PubMed ID: 17872464 [Abstract] [Full Text] [Related]
23. Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries. Laitinen I, Marjamäki P, Haaparanta M, Savisto N, Laine VJ, Soini SL, Wilson I, Leppänen P, Ylä-Herttuala S, Roivainen A, Knuuti J. Eur J Nucl Med Mol Imaging; 2006 Dec 09; 33(12):1461-7. PubMed ID: 16845513 [Abstract] [Full Text] [Related]
27. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Int J Cardiovasc Imaging; 2016 Jan 09; 32(1):49-59. PubMed ID: 25898891 [Abstract] [Full Text] [Related]
28. Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM. Nie X, Randolph GJ, Elvington A, Bandara N, Zheleznyak A, Gropler RJ, Woodard PK, Lapi SE. Nucl Med Biol; 2016 Sep 09; 43(9):534-542. PubMed ID: 27372286 [Abstract] [Full Text] [Related]
29. Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques. Saraste A, Laitinen I, Weidl E, Wildgruber M, Weber AW, Nekolla SG, Hölzlwimmer G, Esposito I, Walch A, Leppänen P, Lisinen I, Luppa PB, Ylä-Herttuala S, Wester HJ, Knuuti J, Schwaiger M. J Nucl Cardiol; 2012 Aug 09; 19(4):775-84. PubMed ID: 22527796 [Abstract] [Full Text] [Related]
30. Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis. Wenning C, Kloth C, Kuhlmann MT, Jacobs AH, Schober O, Hermann S, Schäfers MA. Atherosclerosis; 2014 Jun 09; 234(2):276-82. PubMed ID: 24704630 [Abstract] [Full Text] [Related]
31. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. J Nucl Med; 2009 Jun 09; 50(6):959-65. PubMed ID: 19443582 [Abstract] [Full Text] [Related]
37. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI. Li X, Bauer W, Israel I, Kreissl MC, Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, Frantz S, Samnick S. Arterioscler Thromb Vasc Biol; 2014 Aug 09; 34(8):1661-7. PubMed ID: 24903095 [Abstract] [Full Text] [Related]
39. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH, Tian P, Xu JP, Wang ZZ, Zhao XZ, Nie MX, Zhang MD, Zhao QM, Zhao BT, Song SJ. Zhonghua Nei Ke Za Zhi; 2019 Nov 01; 58(11):808-813. PubMed ID: 31665855 [Abstract] [Full Text] [Related]